Kyabaggu D, Ejobi F, Olila D
Department of Physiological Sciences, Faculty of Veterinary Medicine, Makerere University, Kampala.
Afr Health Sci. 2007 Dec;7(4):214-22.
Urinary tract infections (UTIs) are among the most common human infections. Many urinary tract bacteria are capable of expressing drug resistance. Resistant bacteria may be present from the commencement of the infection or may develop during treatment. This study focused on the problem of antibiotic resistance to the first-line drugs that were used to treat patients presenting with urinary tract infections at Rubaga hospital in Kampala, Uganda.
The objective of this study was to isolate and identify the major bacterial pathogens of symptomatic and asymptomatic UTIs among patients at Rubaga hospital. Furthermore, the study sought to determine the antimicrobial susceptibility patterns of the major bacterial isolates to the first-line drugs used to treat UTIs at Rubaga hospital.
Urine samples were aseptically collected and examined microscopically and were microbiologically cultured on blood agar, nutrient agar and on MacConkey agar. The isolates obtained were then identified using standard tests and tested for antimicrobial sensitivity by the Kirby-Bauer technique.
The isolated pathogens included Escherichia coli (10.9%), Staphylococcus (31.9%), Streptococcus (9.2%), Klebsiella species (21.0%) and Proteus species (10.1%). 20 (16.8%) of the isolates were lactose fermenting gram-negative rods that were also indole-negative. These isolates were termed 'unclassified coliforms' in this study but were probably Enterobacter species. On antimicrobial susceptibility testing, all the gram-negative isolates were significantly resistant to amoxycillin, cotrimoxazole, erythromycin, and to nalidixic acid; but were susceptible to nitrofurantoin. Among the gram-negative isolates, only Klebsiella species were significantly resistant (p<0.05) to ciprofloxacin. The gram-positive cocci were susceptible to amoxycillin, ciprofloxacin, and to erythromycin but resistant to cotrimoxazole and nalidixic acid. Unlike the Staphylococcus species that were significantly resistant to nitrofurantoin, Streptococcus species were moderately susceptible to the drug.
The common urinary tract bacteria detected in Rubaga hospital in Uganda were most sensitive to Ciprofloxacin and Nitrofurantoin.
尿路感染(UTIs)是最常见的人类感染之一。许多泌尿道细菌能够表达耐药性。耐药菌可能在感染开始时就已存在,也可能在治疗过程中产生。本研究聚焦于乌干达坎帕拉鲁巴加医院用于治疗尿路感染患者的一线药物的抗生素耐药性问题。
本研究的目的是分离和鉴定鲁巴加医院有症状和无症状尿路感染患者中的主要细菌病原体。此外,该研究旨在确定主要细菌分离株对鲁巴加医院用于治疗尿路感染的一线药物的抗菌药敏模式。
无菌采集尿液样本,进行显微镜检查,并在血琼脂、营养琼脂和麦康凯琼脂上进行微生物培养。然后使用标准测试鉴定获得的分离株,并通过 Kirby-Bauer 技术测试其抗菌敏感性。
分离出的病原体包括大肠杆菌(10.9%)、葡萄球菌(31.9%)、链球菌(9.2%)、克雷伯菌属(21.0%)和变形杆菌属(10.1%)。20株(16.8%)分离株为乳糖发酵革兰氏阴性杆菌,且吲哚试验阴性。在本研究中,这些分离株被称为“未分类大肠菌群”,但可能是肠杆菌属。在抗菌药敏试验中,所有革兰氏阴性分离株对阿莫西林、复方新诺明、红霉素和萘啶酸均有显著耐药性;但对呋喃妥因敏感。在革兰氏阴性分离株中,只有克雷伯菌属对环丙沙星有显著耐药性(p<0.05)。革兰氏阳性球菌对阿莫西林、环丙沙星和红霉素敏感,但对复方新诺明和萘啶酸耐药。与对呋喃妥因有显著耐药性的葡萄球菌不同,链球菌对该药物中度敏感。
在乌干达鲁巴加医院检测到的常见泌尿道细菌对环丙沙星和呋喃妥因最为敏感。